Vesicular stomatitis virus infection promotes immune evasion by preventing NKG2D-ligand surface expression
- PMID: 21857986
- PMCID: PMC3153473
- DOI: 10.1371/journal.pone.0023023
Vesicular stomatitis virus infection promotes immune evasion by preventing NKG2D-ligand surface expression
Abstract
Vesicular stomatitis virus (VSV) has recently gained attention for its oncolytic ability in cancer treatment. Initially, we hypothesized that VSV infection could increase immune recognition of cancer cells through induction of the immune stimulatory NKG2D-ligands. Here we show that VSV infection leads to a robust induction of MICA mRNA expression, however the subsequent surface expression is potently hindered. Thus, VSV lines up with human cytomegalovirus (HCMV) and adenovirus, which actively subvert the immune system by negatively affecting NKG2D-ligand surface expression. VSV infection caused an active suppression of NKG2D-ligand surface expression, affecting both endogenous and histone deacetylase (HDAC)-inhibitor induced MICA, MICB and ULBP-2 expression. The classical immune escape mechanism of VSV (i.e., the M protein blockade of nucleocytoplasmic mRNA transport) was not involved, as the VSV mutant strain, VSV(ΔM51), which possess a defective M protein, prevented MICA surface expression similarly to wild-type VSV. The VSV mediated down modulation of NKG2D-ligand expression did not involve apoptosis. Constitutive expression of MICA bypassed the escape mechanism, suggesting that VSV affect NKG2D-ligand expression at an early post-transcriptional level. Our results show that VSV possess an escape mechanism, which could affect the immune recognition of VSV infected cancer cells. This may also have implications for immune recognition of cancer cells after combined treatment with VSV and chemotherapeutic drugs.
Conflict of interest statement
Figures





Similar articles
-
The HHV-6A Proteins U20 and U21 Target NKG2D Ligands to Escape Immune Recognition.Front Immunol. 2021 Oct 15;12:714799. doi: 10.3389/fimmu.2021.714799. eCollection 2021. Front Immunol. 2021. PMID: 34721381 Free PMC article.
-
Upregulated expression of NKG2D and its ligands give potential therapeutic targets for patients with thymoma.Cancer Gene Ther. 2015 Jul;22(7):368-74. doi: 10.1038/cgt.2015.29. Epub 2015 Jun 26. Cancer Gene Ther. 2015. PMID: 26113176
-
Metabolism of short-chain fatty acid propionate induces surface expression of NKG2D ligands on cancer cells.FASEB J. 2020 Nov;34(11):15531-15546. doi: 10.1096/fj.202000162R. Epub 2020 Sep 30. FASEB J. 2020. PMID: 32996653
-
Leveraging NKG2D Ligands in Immuno-Oncology.Front Immunol. 2021 Jul 29;12:713158. doi: 10.3389/fimmu.2021.713158. eCollection 2021. Front Immunol. 2021. PMID: 34394116 Free PMC article. Review.
-
Battle of the midgets: innate microRNA networking.RNA Biol. 2012 Jun;9(6):792-8. doi: 10.4161/rna.19717. Epub 2012 May 23. RNA Biol. 2012. PMID: 22617882 Review.
Cited by
-
Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer.J Gen Virol. 2012 Dec;93(Pt 12):2529-2545. doi: 10.1099/vir.0.046672-0. Epub 2012 Oct 10. J Gen Virol. 2012. PMID: 23052398 Free PMC article. Review.
-
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination.NPJ Vaccines. 2020 Apr 14;5(1):32. doi: 10.1038/s41541-020-0179-4. eCollection 2020. NPJ Vaccines. 2020. PMID: 32337075 Free PMC article.
-
Viral Evasion of Natural Killer Cell Activation.Viruses. 2016 Apr 12;8(4):95. doi: 10.3390/v8040095. Viruses. 2016. PMID: 27077876 Free PMC article. Review.
-
Concise review: immunologic lessons from solid organ transplantation for stem cell-based therapies.Stem Cells Transl Med. 2013 Feb;2(2):136-42. doi: 10.5966/sctm.2012-0125. Epub 2013 Jan 24. Stem Cells Transl Med. 2013. PMID: 23349327 Free PMC article. Review.
-
Oncolytic measles virus enhances antitumour responses of adoptive CD8+NKG2D+ cells in hepatocellular carcinoma treatment.Sci Rep. 2017 Jul 12;7(1):5170. doi: 10.1038/s41598-017-05500-z. Sci Rep. 2017. PMID: 28701757 Free PMC article.
References
-
- Stojdl DF, Lichty B, Knowles S, Marius R, Atkins H, et al. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med. 2000;6:821–825. - PubMed
-
- Lichty BD, Power AT, Stojdl DF, Bell JC. Vesicular stomatitis virus: re-inventing the bullet. Trends Mol Med. 2004;10:210–216. - PubMed
-
- Clinton GM, Little SP, Hagen FS, Huang AS. The matrix (M) protein of vesicular stomatitis virus regulates transcription. Cell. 1978;15:1455–1462. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources